Navigation Links
Cephalon Presents Positive Results for Fentora in Breakthrough Pain,,,Associated with Neuropathic Conditions

ned to provide early-onset analgesia via a chemical reaction that enhances fentanyl absorption across the inner lining of the cheek. Cephalon is pursuing clinical development of FENTORA in breakthrough pain associated with conditions other than cancer, including chronic neuropathic pain, and expects to file a supplemental New Drug Application this year. FENTORA is not approved for use in these conditions.

The multi-center study evaluated FENTORA in adult patients with chronic neuropathic pain who were diagnosed with a variety of conditions including diabetic peripheral neuropathy, traumatic injury, postherpetic neuralgia and complex regional pain syndrome (CRPS) -- a chronic condition caused by a nerve disorder that occurs at the site of injury, often a fractured arm or leg. All patients were already receiving various around-the-clock opioid medications for persistent pain, and short-acting opioids for their one to four episodes of breakthrough pain a day.

The open label titration phase of the study enrolled 103 patients who were individually titrated to a dose that provided adequate pain relief for at least two of three breakthrough pain flares. Of these, 102 patients received at least 1 dose of FENTORA and 80 patients (78 percent) identified a successful dose with acceptable side effects. Only six patients (6 percent) withdrew from the study due to lack of efficacy. In the randomized, placebo- controlled, double-blind treatment phase in which all patients were exposed to both FENTORA and placebo, data from 75 patients (95 percent of patients who reached a successful dose) were evaluable for efficacy. Key study findings include:


    -- The primary efficacy measure, the Sum of Pain Intensity Differences



       from 5 though 60 minutes (SPID60), demonstrated significantly higher



       scores compared to placebo (9.6 +/- 0.75 vs. 5.7 +/- 0.72, p<0.0001).



    -- Reduction in
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/6/2009)... Boston Scientific Corpo...eached an agreement in principle with the U.S. Dep...ries issued by its Guidant subsidiary in 2005. Th... to Boston Scientific,s 2006 acquisition of Guidan...d an investigation by the U.S. Attorney,s Office i...
(Date:11/6/2009)...Newswire-FirstCall/ -- Ardea Biosciences, Inc. (Na...the development of small-molecule therapeutics for...iciency virus (HIV), today reported recent accompl...er and nine months ended September 30, 2009. ,...91104/ARDEALOGO ) ,, "Since our last quarterly ...
(Date:11/6/2009)...wswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulle...Atlanta-based, biopharmaceutical company developin...an Immunodeficiency Virus) and other infectious ag...cial results and provided an operational update. ,...ecutive Officer commented, "We are pleased with ou...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 1Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 2Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3
... INCLUDE JACKSON BROWNE, MORGAN FREEMAN, SAMUEL L....OODARD, AND FOREST WHITAKER, LOS ANGELES, Oct. 24... South Africa (ANSA) will host "Shaking The Blues,...geles. The evening combines,the power of music and...nal,to the global -- and make a difference in the ...
...hase IIIb clinical study presented at CHEST 2007 o...olution with tiotropium for COPD ...ata presented today at,CHEST 2007, the annual scie...hysicians (ACCP), demonstrate concomitant use of n...ed improved bronchodilation over tiotropium,monoth...
Other Medicine Technology:Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 2Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
(Date:11/8/2009)... Praises House Passage of Health Care Reform Bill ...care, improve coverage for all Americans ,, CH...e United States House of Representatives passed by...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...
(Date:11/7/2009)...NGTON , Nov. 7 Speak...support of H.R. 3962, the Affordable Health Care f...ation later tonight. Below are the Speaker,s rema... is an historic moment for our nation and for Amer...very party and political philosophy -- as far back...
(Date:11/7/2009)...ON, Nov. 7 Members of t...e an emergency resolution rescinding the AMA,s sup...ans that they are responsible to their PATIENTS, n..., Director of Policy for the Association of Americ..., a coalition of other medical groups. ,, "If ...
(Date:11/7/2009)... Nov. 7 Americans United for Life Action endorses...-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith ...ney from going to abortion in health care reform. ...d CEO Dr. Charmaine Yoest said, "Americans United ...orth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendm...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...ssociation Requests AAP Instead Focus on Removing,...ical Treatments for,Children with Autism, CHICAGO...) has initiated a "parent spokesperson" campaign t...ngoing,response to media stories regarding autism ...
...ebruary 11, 2008 -- In forests of the northeastern...nt dissolved forms of sulfur and nitrogen in preci...e in the snowpack and are released to groundwater ...n in poorly buffered soils, ultimately threatening...
... Feb. 15 Canine companions have a paw,up on our f...inarian,leaving cats shortchanged and in need of s...eport appearing in the Feb. 15, 2008, edition,of t... Pet owners, the study found, generally have stro...
...uary 21st at 12:00 p.m. Pacific Time -, MONTVALE,... SYI ) announced today that Noah Berkowitz, M.D.,...nvista will present at,the Roth 20th Annual OC Gro...ifornia. The conference is being held,from Februar...
...ed contraceptive become the first targeted therapy...ation of tamoxifen, from cast-off to lifesaver, la... selective estrogen receptor modulators that coul...e Fox Chase Cancer Center in Philadelphia. , Tod...
...h.---Oxygen, although essential for human life, ca...t toxic to important molecules inside our cells. T...eases, such as Alzheimer,s, heart disease and canc...ademy of Sciences (PNAS), University of Michigan r...
Other Medicine News:Health News:AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity 2Health News:Melting snow provides clues for acidification 2Health News:Coming to the Defense of Cats 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators 2
...sional Diagnostics is a leading provider of immuno... test menu that includes kits for autoimmune disea...llaneous conjugates and components. Our Impact IFA...ates and kit sizes to choose from. Kit components ...
...sional Diagnostics is a leading provider of immuno... test menu that includes kits for autoimmune disea...llaneous conjugates and components. Our Impact IFA...ates and kit sizes to choose from. Kit components ...
...s disease ELISA products make us a leader in this ...tegration into the busy laboratory, our Infectious...ity and run-to-run consistency. Our Infectious Dis... for a wide range of serological assays including ...
...s disease ELISA products make us a leader in this ...tegration into the busy laboratory, our Infectious...ity and run-to-run consistency. Our Infectious Dis... for a wide range of serological assays including ...
Medicine Products: